Here's Why The Cooper Companies (COO) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

09.06.2026

Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

09.06.2026

Cooper Companies: Demand Growth And Earnings Beat, Needs Stronger ROE And Profit Margins

The Cooper Companies gets a hold rating for my initial coverage. Strengths are driven by the top line and market demand for contact lenses for a variety of eye conditions, with only a handful of key peers in this niche. Margin and ROE improvement remains a challenge, to improve metrics vs peers like Alcon, Bausch & Lomb, and Johson & Johnson, as well as competing on product innovation.

09.06.2026

The Cooper Companies: I Can See A Potential Upgrade On The Horizon

The Cooper Companies, Inc. remains a Hold as valuation nears attractive levels but litigation risk and mixed profitability warrant caution. Revenue growth is robust, particularly in the CooperVision segment, with strong performance in EMEA and the Americas offsetting Asia Pacific softness. Litigation charges from embryo culture media recalls have materially impacted reported profitability, but are not expected to alter COO's long-term outlook.

08.06.2026

The Cooper Companies (COO) Reliance on International Sales: What Investors Need to Know

Evaluate The Cooper Companies' (COO) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

05.06.2026

COO Stock Rises on Q2 Earnings Beat, FY26 Revenue Guidance Trimmed

Cooper Companies beats Q2 EPS and sales estimates as CooperVision and CooperSurgical hit record revenues, even with a GAAP loss from recall litigation.

05.06.2026

Cooper Cos. Is One of Today's Top S&P 500 Stocks.

The medical device maker gave an update on its troubled CooperSurgical business segment that was music to Wall Street's ears.

Видео

07.01.2026

Positive

'Forgotten' stocks that could be 2026 powerhouses

Повышения / Понижения рейтинга

Тикер	Фирма	Изменение рейтинга	Целевая цена	Дата
COO	Needham	Buy	$101 >> $86	June 5th 2026

Пресс-релизы

04.06.2026

CooperCompanies Announces Second Quarter 2026 Results

SAN RAMON, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2026.

The Cooper Companies, Inc. (COO)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

The Cooper Companies, Inc. (COO)

Here's Why The Cooper Companies (COO) is a Strong Value Stock

Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term

Cooper Companies: Demand Growth And Earnings Beat, Needs Stronger ROE And Profit Margins

The Cooper Companies: I Can See A Potential Upgrade On The Horizon

The Cooper Companies (COO) Reliance on International Sales: What Investors Need to Know

COO Stock Rises on Q2 Earnings Beat, FY26 Revenue Guidance Trimmed